Form4insider filings, from the source

SEC Form 4 · accession 0001231919-26-000869

Latigo Biotherapeutics, Inc. · LTGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kush Parmar
10% Owner
Period of report
Aug 10, 2026
Accepted (ET)
Aug 12, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002056611

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 10, 2026C4,975,543—A4,975,543IBy 5AM Ventures VI, L.P.
Common StockF1,F3Aug 10, 2026C2,350,419—A2,350,419IBy 5AM Opportunities II, L.P.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF2,F1—Aug 10, 2026C3,152,305D——Common Stock3,152,3050I
Series A-2 Preferred StockF2,F1—Aug 10, 2026C1,823,238D——Common Stock1,823,2380I
Series A-2 Preferred StockF3,F1—Aug 10, 2026C866,018D——Common Stock866,0180I
Series B Preferred StockF3,F1—Aug 10, 2026C1,484,401D——Common Stock1,484,4010I

Explanation of responses